[1]
J. Lin, “Research Advances and Future Directions of Biotechnology in the Treatment of Myasthenia Gravis”, IJPHMR, vol. 6, no. 7, pp. 18–25, Aug. 2026, doi: 10.62051/ijphmr.v6n7.03.